Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Hepatopulmonary Syndrome in Liver Cirrhosis
NCT01518595Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2011
- Primary completion
- Apr 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in hepatopulmonary syndrome (HPS), sponsored by Medical University of Vienna. Started Oct 2011; status: terminated.
02
Drugs
bosentan
03
Conditions
hepatopulmonary syndrome (HPS)
Beyond the preview
Go deeper on NCT01518595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518595.